Caligan Partners as of March 31, 2025
Portfolio Holdings for Caligan Partners
Caligan Partners holds 16 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Liquidia Corporation Com New (LQDA) | 25.0 | $120M | 8.1M | 14.75 | |
| Verona Pharma Sponsored Ads (VRNA) | 19.0 | $91M | 1.4M | 63.49 | |
| Exelixis (EXEL) | 11.8 | $56M | 1.5M | 36.92 | |
| Mineralys Therapeutics (MLYS) | 7.1 | $34M | 2.1M | 15.88 | |
| Evolus (EOLS) | 6.9 | $33M | 2.7M | 12.03 | |
| Sage Therapeutics (SAGE) | 5.1 | $24M | 3.1M | 7.95 | |
| BioCryst Pharmaceuticals (BCRX) | 4.9 | $23M | 3.1M | 7.50 | |
| Anika Therapeutics (ANIK) | 4.5 | $22M | 1.4M | 15.03 | |
| Agios Pharmaceuticals (AGIO) | 4.3 | $21M | 701k | 29.30 | |
| Revolution Medicines (RVMD) | 3.4 | $16M | 465k | 35.36 | |
| Merus N V (MRUS) | 3.3 | $16M | 377k | 42.09 | |
| Y Mabs Therapeutics | 2.2 | $10M | 2.3M | 4.43 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.7 | $7.9M | 1.3M | 6.25 | |
| Verrica Pharmaceuticals | 0.8 | $4.0M | 9.0M | 0.44 | |
| Rezolute Com New (RZLT) | 0.1 | $410k | 141k | 2.90 | |
| Tyra Biosciences (TYRA) | 0.0 | $233k | 25k | 9.30 |
